retatrutide research study The Effect of on Kidney Parameters in Participants With Type 2 Diabetes Mellitus and/or Obesity Retatrutide—A Game Changer in Obesity

#TaibaRare #RareMetabolicDisease #PatientAwareness #LipodystrophyAwareness #RareDisease #MetabolicHealth #WorldLipodystrophyDay #RareDisorders #ChronicIllness To view or add a comment, sign in Ashley Shoemaker, MD, MSci, of Vanderbilt Health discusses the FDA approval of setmelanotide (Imcivree), the first targeted therapy for acquired hypothalamic obesity in patients 4+ years

The Text Messages The first shot came almost a year ago, well before the NYT profile and most of the digital health world had heard the name

What This Regulatory Difference Means for Patients Patients considering compounded weight loss medications should understand that these products, although prepared by licensed pharmacies using pharmaceutical ingredients, have not been evaluated by the FDA as finished drugs

Yes, some doctors have their own personal preferences and feelings towards using drugs for weight loss, and this can cause some doctors to tell their patients to exercise and eat healthier instead of recommending semaglutides for weigh loss

Another leading drug shortage tracker, from the American Society of Health-System Pharmacists, also shows availability of tirzepatide and semaglutide

Evidence suggests that Cinnulin PF, a cinnamon extract that is water soluble and has a 20:1 ratio, can help with blood glucose control in several ways